Issue 35, 2025

Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation

Abstract

Correction for ‘Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation’ by Samar M. Mahgoub et al., Anal. Methods, 2025, 17, 6215–6230, https://doi.org/10.1039/D5AY00698H.

Associated articles

Article information

Article type
Correction
Submitted
12 Aug 2025
Accepted
12 Aug 2025
First published
28 Aug 2025
This article is Open Access
Creative Commons BY license

Anal. Methods, 2025,17, 7126-7126

Correction: Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation

S. M. Mahgoub, A. S. Alawam, H. A. Rudayni, A. A. Allam, K. H. Ezzat, S. A. A. Elsuccary, A. M. Radalla and R. Mahmoud, Anal. Methods, 2025, 17, 7126 DOI: 10.1039/D5AY90112J

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements